Impact research.
Close gaps.
Earn revenue.
Our innovative, turnkey ancillary program helps close critical cancer screening gaps by frictionlessly enrolling patients in research studies and thoughtfully managing them through the process.
Bringing scale and diversity to clinical research.
Aton Health connects biotech study sponsors with our unique network of healthcare providers to fast-track the development of cancer and chronic disease observational research.
Meeting patients and providers where they are.
Aton Health's unique, decentralized model allows virtually everyone to play an active role in advancing critical research.
There's a wave of research being conducted in early cancer and disease screening, but most providers and patients remain underrepresented.
Less than
9%
of individuals in the U.S. have been asked to participate in clinical research.
Only
10%
of physicians participate in research.
Greater than
70%
of participants live more than two hours away from a research site.
A New Model
Aton Health's approach empowers people, providers and sponsors to actively participate in increasing survival rates for cancer and other chronic diseases.
How the Aton Health Model Works
1Participant
Identification
Our technology and processes allows us to match patients to studies in real time, along with identifying those who are overdue for cancer screening.
2Screening Awareness
We provide turnkey education and awareness materials to drive more patients to annual screening.
3Participant
Engagement
We conduct recruitment and eligibility screening, and obtain all necessary consent for enrollment.
4Study
Execution
We facilitate bio sample collection, additional data requirements and payment to participants.
5Study
Delivery
We deliver all required source documentation, quality assurance, data management and protocol compliance.
Good for Screening.
Aton Health is not only committed to accelerating the development of next-generation early cancer detection tests, but in helping all patients understand the importance of screening, the options available to them and where to go for additional information.
Good for Outcomes.
Better, more compliant screening means better outcomes. Aton Health focuses on bringing large, diverse, and often underserved patient populations into clinical research, which results in increased screening compliance and HEDIS/GAP closure.
Good for Revenue.
Practices receive a meaningful, turnkey ancillary revenue opportunity that requires absolutely no changes to current physician behavior, disruptions to existing workflows, increased effort or investment.
Good for Patients.
In addition to the rare opportunity to play an active roll in impacting early cancer and disease detection research, the monetary incentives can often encourage patients who might not get screened otherwise.
Good for
Studies.
Aton Health's unique provider partnerships allow us to more efficiently match participants to studies and collect all data required by biotech study sponsors. Plus, because we're not limited by brick-and-mortar sites, we enable non-research clinics to participate, while ensuring that the study protocol is seamlessly integrated into the patient’s care pathway.
"Being able to decentralize research and find patients that are in a center that does not traditionally have a research site, has been exciting not only for our physicians, but for our patients because they can now be involved in these research studies."
Dr. Casey Chapman, Chief Medical Officer, GI Alliance, and Principal Investigator
Aton Health by the Numbers
15M+
Patients Represented
300+
# of Research Affiliate Locations
950+
Physicians Represented
1M+
Annual Screening Procedures Represented
Let's Talk
We are actively seeking partners to participate in early cancer- and disease-detection studies.
Copyright 2024, Aton Holdings, Inc.